UnitedHealth Group’s turnaround plan to trade membership for improved profit margins will result in lower revenue in 2026, as the healthcare giant attempts to recover from a disastrous period of setbacks that …
The first human test of a rejuvenation method will begin “shortly”
When Elon Musk was at Davos last week, an interviewer asked him if he thought aging could be reversed. Musk said he hasn’t put much time into the problem but suspects it is “very solvable” and that when scientists discover why we age, it’s going to be something “obvious.” Not long after, the Harvard professor […]
OpenAI’s latest product lets you vibe code science
OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The firm has released a free LLM-powered tool for scientists called Prism, which embeds ChatGPT in a text editor for writing scientific papers. The idea is to put ChatGPT front and center inside software that scientists use to write up […]
WorldLeaks Extortion Group Claims It Stole 1.4TB of Nike Data
The sportswear brand is investigating an alleged breach of its network that exposed some 188,347 files of highly sensitive corporate data.
WorldLeaks Extortion Group Claims It Stole 1.4TB of Nike Data
The sportswear brand is investigating an alleged breach of its network that exposed some 188,347 files of highly sensitive corporate data.
FDA lifts hold on one of two Phase 3 gene editing studies by Intellia
The FDA has allowed Intellia Therapeutics to resume one of its two pivotal trials of a gene editing therapy for transthyretin amyloidosis, which is a disease caused by misfolded proteins. Intellia
Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma
Insilico Medicine is having quite a month. Fresh from deals with Servier and Hygtia Therapeutics, the biotech has signed a new collaboration with Shanghai-based Qilu Pharmaceutical worth nearly …
Boehringer Super Bowl ad recruits Octavia Spencer, Sofía Vergara for mission to boost kidney testing
Boehringer Ingelheim’s mission for Super Bowl LX viewers, should they choose to accept it, is to learn more about urine albumin-to-creatinine ratio screening to monitor kidney health in people with certain risk factors.
AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
Plus, news about Vial, Skyhawk and Gimv: AstraZeneca stops cardio drug: The UK pharma giant has terminated a Phase 1 of an oral cardio drug candidate called AZD0233, according …
Virtual women’s health company Wisp buys TBD Health
Wisp, a women’s telehealth company, bought sexual healthcare startup TBD Health, as virtual care companies look to become more comprehensive in the services they offer. Terms of the deal, which closed near …
China clears its first drug for chronic hepatitis D
Huahei Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.
Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere
Boehringer Ingelheim will pair up with Simcere Pharmaceutical in one of the hottest targets in immunology. For €42 million ($50 million) upfront, the German pharma will tap into Simcere’s preclinical TL1AxIL-23p19 bispecific antibody for inflammatory …